Restoring Colistin Sensitivity in Multidrug-Resistant Pathogenic E. coli Using Cinacalcet Hydrochloride
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111574 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chenchen Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Biopesticide Engineering Research Centre, Wuhan 430000, China. Hauptthemen laut MEDLINE: Colistin, Escherichia coli, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Hubei Agricultural Science Technology Innovation Center.
Abstract (Originalsprache)
Restoring colistin’s efficacy is crucial in addressing the resistance crisis of colistin. This study utilized a high-throughput screening method to identify 43 compounds from 800 FDA-approved drugs that exhibited significant antibacterial effects when combined with colistin. Among these, cinacalcet hydrochloride (CH) was selected for its potential synergistic effect with colistin against multidrug-resistant (MDR) E. coli strains, including mcr-1-positive strains. A series of experiments revealed that the combination of CH and colistin showed strong synergy, especially in mcr-1-positive strains, restoring colistin sensitivity. The combination significantly inhibited bacterial growth and reduced CFU counts more effectively than either drug alone. Additionally, CH and colistin together significantly inhibited biofilm formation and eradicated existing biofilms, as visualized through confocal microscopy. Mechanistic studies showed that the combination increased bacterial membrane permeability and disrupted membrane integrity. The treatment also elevated extracellular ATP release and ROS production, indicating oxidative stress-induced bacterial death. Safety evaluations showed that the combination did not increase toxicity in host cells. Finally, animal models further validated the combination’s efficacy. Overall, this study showed that the combination of colistin and CH significantly restored colistin sensitivity in mcr-1-positive E. coli, revealing their synergistic antibacterial mechanism involving membrane damage and oxidative stress, with promising clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Biopesticide Engineering Research Centre, Wuhan 430000, China.
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430000, China.
ORCID-Profile: Manli Liu
Förderung
- National Key Research and Development Program
- Hubei Agricultural Science Technology Innovation Center
Zitieren
APA
Wang, C., Zhang, Z., Liu, D., Li, X., Zhang, Z., Zeng, Y., Dong, W., Tan, C., & Liu, M. (2024). Restoring Colistin Sensitivity in Multidrug-Resistant Pathogenic E. coli Using Cinacalcet Hydrochloride. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111574
Vancouver
Wang C, Zhang Z, Liu D, Li X, Zhang Z, Zeng Y, et al. Restoring Colistin Sensitivity in Multidrug-Resistant Pathogenic E. coli Using Cinacalcet Hydrochloride. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111574
BibTeX
@article{Wang2024,
author = {Wang, Chenchen and Zhang, Ziyi and Liu, Di and Li, Xiaodan and Zhang, Zhaoran and Zeng, Yan and Dong, Wenqi and Tan, Chen and Liu, Manli},
title = {Restoring Colistin Sensitivity in Multidrug-Resistant Pathogenic E. coli Using Cinacalcet Hydrochloride},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111574}
}
EUVIMED